Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
01/06/2005 | US20050004136 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful as neurokinin receptor modulators |
01/06/2005 | US20050004135 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
01/06/2005 | US20050004134 Adenosine antagonists; having 6-oxo-1,6-dihydro-3-pynidazinyl functionality; synthesis |
01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
01/06/2005 | US20050004132 Pain, immune diseases, inflammatory disorders; low toxicity; such as 1-[2-(3-(4-Pyridyl)phenyl)ethyl]-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine 1-oxide |
01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
01/06/2005 | US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
01/06/2005 | US20050004099 Spiroazabicyclic heterocyclic compounds |
01/06/2005 | US20050004096 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
01/06/2005 | US20050004082 Ether compounds |
01/06/2005 | US20050004081 Pharmaceutical combinations for the treatment of cancer |
01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
01/06/2005 | US20050004056 Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis |
01/06/2005 | US20050004047 Bactericides; antiprotozoa agents |
01/06/2005 | US20050004035 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
01/06/2005 | US20050004016 Quantitative analysis of amino acid sequences; genetic engineering |
01/06/2005 | US20050003529 Stem cells and method of separating the same |
01/06/2005 | US20050003028 Sylimarin isolated from St Mary thistle plant combined with taraxaci radix dandelion root, menthae piperitae folium peppermint leaf, helichrysi flos and menyanthes trifoliata folium buckbean leaf |
01/06/2005 | US20050003015 Producing isoleucine, leucine and valine containing particles having reduced bitterness and odor; small volume dose |
01/06/2005 | US20050003005 Basic inorganic salt acid resistant coating; antiulcer agents, benzimidazole derivatives |
01/06/2005 | US20050003002 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
01/06/2005 | US20050002949 Prevention and treatment of irritable bowel syndrome |
01/06/2005 | US20050002875 Peptide which binds to integrin |
01/06/2005 | US20050002874 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
01/06/2005 | CA2839032A1 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
01/06/2005 | CA2535980A1 P38 kinase inhibitor compositions and methods of use |
01/06/2005 | CA2528619A1 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
01/06/2005 | CA2527079A1 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
01/06/2005 | CA2526490A1 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
01/06/2005 | CA2525788A1 Anti-adhesion composites and methods of use thereof |
01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
01/05/2005 | EP1493441A1 Therapeutic agent for food competence disorder in stomach |
01/05/2005 | EP1493431A2 Use of an extract of bauhinia for the preparation of pharmaceutical and cosmetic compositions |
01/05/2005 | EP1492868A2 Method of modulating inflammatory response |
01/05/2005 | EP1492797A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
01/05/2005 | EP1492795A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
01/05/2005 | EP1492793A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
01/05/2005 | EP1492789A1 Tropane derivatives as ccr5 modulators |
01/05/2005 | EP1492784A2 Substituted 2,3-diphenyl pyridines |
01/05/2005 | EP1492781A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
01/05/2005 | EP1492780A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as ptpase 1b inhibitors |
01/05/2005 | EP1492779A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
01/05/2005 | EP1492778A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors |
01/05/2005 | EP1492777A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors |
01/05/2005 | EP1492775A2 Oxo-azabicyclic compounds |
01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
01/05/2005 | EP1492761A2 Amino acids with affinity for the alpha-2-delta-protein |
01/05/2005 | EP1492756A1 Novel thyroid receptor ligands |
01/05/2005 | EP1492555A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell population |
01/05/2005 | EP1492549A1 Compositions and methods for augmenting kidney function |
01/05/2005 | EP1492544A1 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
01/05/2005 | EP1492536A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
01/05/2005 | EP1492530A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors |
01/05/2005 | EP1492512A1 Method for systemic drug delivery through the nail |
01/05/2005 | EP1492510A1 Low dose liquid entecavir formulations and use |
01/05/2005 | EP1492415A2 Method of improving absorption of vitamin e by a pet animal |
01/05/2005 | EP1492414A2 Method and dietary composition for improving fat digestibility |
01/05/2005 | EP1492413A2 Method and dietary composition for improving lipid digestibility |
01/05/2005 | EP1244440B1 Agonists specific for the peripheral cannabinoid receptor |
01/05/2005 | EP1226126B1 Pyrimidine derivatives |
01/05/2005 | EP1133300B1 Desmethylolanzapine compositions and methods |
01/05/2005 | CN1561391A Recombinant bacterial phytases and uses thereof |
01/05/2005 | CN1561387A Probiotic bifidobacterium strains |
01/05/2005 | CN1561327A Novel aminobenzoephenones |
01/05/2005 | CN1561231A Inhibition of neonatal hyperbilirubinemia in breast fed infants |
01/05/2005 | CN1561227A Method for treating hepatitis C virus infection in treatment failure patients |
01/05/2005 | CN1561226A Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
01/05/2005 | CN1561223A New drug |
01/05/2005 | CN1561222A Matrix metalloprotease inhibitor |
01/05/2005 | CN1561221A Novel medicinal herbal composition for treating liver diseases and HIV |
01/05/2005 | CN1561220A Method for the treatment of inflammation |
01/05/2005 | CN1561219A Pharmaceutical compounds |
01/05/2005 | CN1561216A Novel compounds |
01/05/2005 | CN1561215A Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist |
01/05/2005 | CN1561214A New formulations and use thereof |
01/05/2005 | CN1561213A New formulations and use thereof |
01/05/2005 | CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
01/05/2005 | CN1560261A Production process of whole silkworm chrysalis powder containing lactoferrbumin and its peptide |
01/05/2005 | CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
01/05/2005 | CN1560059A Synthesis process for Adefovir ester of anti hepatitis type B virus medicine |
01/05/2005 | CN1560055A Tetrahydropyridoethers |
01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
01/05/2005 | CN1560035A 5-hydroxylic indole-3-carboxylic ester kind derivantion |
01/05/2005 | CN1559612A Medicinal mixture for treating digestire system anabrosis |
01/05/2005 | CN1559605A Compound aloe health-care tablet |
01/05/2005 | CN1559595A Medicinal mixture and its preparation method |
01/05/2005 | CN1559588A Yang reinforcing medicine and its preparation method |
01/05/2005 | CN1559567A Chinese medicinal preparation for treating sorethroat, aphtha and its preparation method |
01/05/2005 | CN1559562A Bolus of six drugs including Rehmannia |
01/05/2005 | CN1559558A Oral quick disintegration tablet medicine for treating oral ulcer |
01/05/2005 | CN1559550A New type medicina preparation with one chinese medicinal herb extract ant its preparation method |
01/05/2005 | CN1559541A Spleen fortifying qi boosting capsule and its manufacturing method |
01/05/2005 | CN1559532A Chinese medicinal mixture for treating viral hepatitis |
01/05/2005 | CN1559528A Medicine for treating child diarrhea and its preparation method |
01/05/2005 | CN1559526A Medicine for strengthening child and dispersing food and its preparation method |
01/05/2005 | CN1559522A Houttuynia injection and its processing technology |
01/05/2005 | CN1559521A Bag agent for treating gall stone disease and its preparation method |
01/05/2005 | CN1559520A Chinese medicinal preparation for preventing and curing enteric disease of animal and paultory and its preparation method |